NTRK2 and breast carcinoma: Although increasing evidence implies that altered PI3K/AKT signaling in response to ectopic TrkB promotes tumor formation and metastasis, the molecular mechanisms of TrkB-mediated PI3K/AKT modulation in breast cancer have remained unknown, and none of the findings reported to date hinted at a link between these two sets of phenomena.